Antimicrobial Resistance Raises Concerns Over Infection Treatment in India

New Delhi, October 15: Antimicrobial resistance (AMR) continues to pose a serious challenge to healthcare systems worldwide, raising concerns about the effectiveness of medicines used to treat common bacterial infections and increasing the importance of responsible antibiotic use, laboratory surveillance and effective infection prevention.

The problem occurs when microorganisms develop the ability to survive medicines that would normally eliminate them or stop their growth. Although resistance can develop naturally over time, inappropriate use and overuse of antimicrobial medicines can accelerate the process.

For India, the issue has implications for hospitals, community healthcare facilities and patients receiving treatment for infections ranging from urinary tract infections to severe bloodstream infections.

Medical professionals have repeatedly highlighted the need to ensure that antibiotics are prescribed for appropriate bacterial infections, taken according to medical instructions and not used unnecessarily for illnesses caused by viruses.

The challenge is particularly significant because some resistant infections may require more complex treatment, longer hospital stays and medicines that are more expensive or associated with greater risks of adverse effects.

Understanding the threat of drug resistance

Antimicrobial resistance is a broad term covering resistance in bacteria, viruses, fungi and parasites. Antibiotic resistance refers specifically to bacteria becoming less susceptible or resistant to antibiotics.

When a microorganism develops resistance, medicines that previously worked against it may no longer provide effective treatment. This can make infections harder to manage and increase the risk of complications.

Resistance can spread through several mechanisms. Some microorganisms acquire genetic changes that help them survive exposure to a medicine, while others obtain resistance genes from different microorganisms.

The unnecessary or incorrect use of antibiotics creates conditions that favour resistant bacteria. However, resistance is not limited to patients who have misused medicines. It can also spread through healthcare settings and communities, affecting people who have followed medical advice.

The consequences extend beyond individual infections. Antibiotics are essential for many routine medical procedures, including certain surgeries, cancer treatments and the care of critically ill patients. If effective medicines become less reliable, the risks associated with these treatments can increase.

Inappropriate antibiotic use remains a concern

Antibiotics are designed to treat bacterial infections. They do not directly treat viral illnesses such as influenza or the common cold.

Nevertheless, patients may seek antibiotics for symptoms such as fever, cough or a sore throat without knowing the underlying cause. In many cases, these symptoms can result from viral infections that do not benefit from antibiotic treatment.

Taking antibiotics without an appropriate diagnosis can expose patients to unnecessary side effects while contributing to the broader problem of resistance.

Leftover medicines present another risk. Patients who keep antibiotics from previous prescriptions may use them later for unrelated symptoms, even when the medicine is unsuitable for the condition.

Sharing antibiotics with family members or purchasing them without appropriate medical guidance can also lead to incorrect drug selection and dosing.

Healthcare professionals recommend that patients consult qualified practitioners when treatment is needed and follow the prescribed instructions. Antibiotics should not be started, changed or shared without suitable medical advice.

Patients should also avoid independently changing the duration of treatment. If side effects occur or symptoms fail to improve, they should contact the prescribing professional for guidance rather than making adjustments based on assumptions.

Hospitals must strengthen infection prevention

Healthcare facilities can play a major role in slowing the spread of resistant microorganisms.

Hospitals often treat patients who are vulnerable because of underlying illnesses, surgery, invasive medical devices or weakened immune systems. Resistant bacteria can spread when infection-prevention procedures are not consistently followed.

Hand hygiene remains one of the most important safeguards. Appropriate cleaning and disinfection, sterilisation of medical equipment, safe injection practices and suitable isolation precautions can also reduce transmission.

Hospitals should monitor infections, investigate unusual clusters and maintain reliable systems for reporting laboratory-confirmed resistant organisms.

Patients who require catheters, ventilators or other invasive devices may face increased infection risks. Clinical teams should regularly review whether such devices remain necessary and remove them when they are no longer required.

Improving these practices can reduce the number of infections requiring antibiotics in the first place.

Laboratory surveillance guides treatment

Accurate diagnosis is important when selecting appropriate antimicrobial treatment.

Laboratory testing can help identify the microorganism responsible for an infection and determine which medicines are likely to be effective. Antibiotic susceptibility testing is particularly valuable when resistant bacteria are suspected or when initial treatment does not work.

However, access to timely testing varies between healthcare facilities. Some patients may begin treatment before laboratory results become available, particularly when an infection is severe and delaying therapy could be dangerous.

In such circumstances, doctors may initially prescribe empirical treatment based on the patient’s condition, the likely source of infection and local resistance patterns. The treatment can then be reviewed when additional information becomes available.

Reliable surveillance data help clinicians understand which antibiotics are likely to work in a particular setting. They also help health authorities identify emerging resistance patterns and design more targeted interventions.

India’s National Antimicrobial Resistance Surveillance Network, coordinated by the Indian Council of Medical Research, supports the collection and analysis of resistance data from participating laboratories.

Expanding laboratory capacity, improving data quality and strengthening communication between hospitals and public health authorities can help ensure that surveillance findings inform clinical practice.

Antimicrobial stewardship can improve prescribing

Antimicrobial stewardship refers to coordinated efforts to ensure that antimicrobial medicines are used appropriately.

Hospital stewardship programmes typically involve clinicians, microbiologists, pharmacists and infection-control specialists. Their responsibilities may include reviewing antibiotic prescriptions, monitoring treatment duration and promoting the use of medicines suited to the infection being treated.

One important principle is to use the narrowest effective antibiotic when clinical evidence supports that choice. Broad-spectrum medicines can be necessary in certain situations, but unnecessary use may increase selection pressure for resistance.

Stewardship teams can also review whether intravenous treatment can safely be changed to oral medication and whether antibiotics remain necessary once diagnostic results become available.

These decisions must be based on the patient’s clinical condition and professional judgement. Stewardship is not simply about reducing the number of prescriptions; it is about ensuring that patients receive effective treatment while minimising avoidable exposure.

Community healthcare facilities can also benefit from prescribing guidance, continuing education and access to diagnostic services.

Agriculture and the environment matter too

Antimicrobial resistance cannot be addressed solely within hospitals.

Antimicrobial medicines are used in human healthcare, veterinary medicine and some agricultural settings. Resistant microorganisms and resistance genes can move between people, animals and the environment.

Inappropriate use of antibiotics in animals, inadequate waste management and contamination of water sources may contribute to the wider spread of resistant organisms.

The One Health approach recognises the links between human, animal and environmental health. It encourages coordination among health authorities, veterinary services, agricultural agencies and environmental regulators.

Responsible use of medicines in livestock, improved sanitation, effective wastewater management and stronger monitoring can help reduce opportunities for resistant microorganisms to spread.

These measures are particularly important in areas where healthcare infrastructure, sanitation and environmental monitoring require additional investment.

Public awareness remains essential

Public education is necessary to ensure that efforts to improve antibiotic use reach beyond medical professionals.

Patients should understand that antibiotics are not appropriate for every infection and that unnecessary use can have consequences beyond the individual taking the medicine.

Doctors and pharmacists can explain why a medicine has been prescribed, what benefits are expected and which side effects require attention. Clear communication can also help patients understand why an antibiotic may not be necessary when symptoms are caused by a virus.

Schools, community health programmes and public awareness campaigns can reinforce these messages.

At the same time, responsible use must be supported by access to qualified medical care. Patients should not be discouraged from seeking treatment when they have signs of a serious infection. The goal is to ensure that effective medicines are used when they are clinically needed.

Research and policy support are important

Developing new antibiotics and alternative treatments is one part of the global response to resistance, but scientific innovation alone will not solve the problem.

New medicines can also lose effectiveness if they are used inappropriately or if infection-prevention systems remain weak.

Research into rapid diagnostic tests, vaccines, alternative treatments and improved infection-control technologies may help reduce dependence on antibiotics and identify appropriate treatment sooner.

Health authorities can support progress through surveillance, prescribing standards, laboratory investment and coordinated action across sectors.

India’s National Action Plan on Antimicrobial Resistance provides a policy framework for addressing the issue through surveillance, awareness, infection prevention, research and responsible antimicrobial use.

Implementation requires sustained coordination among central and state governments, healthcare providers, research institutions and other relevant sectors.

Protecting the effectiveness of essential medicines

Antimicrobial resistance is a long-term public health challenge that requires continuous attention rather than isolated interventions.

For patients, the most important steps include using antibiotics only when appropriately prescribed, following professional instructions and avoiding the use of leftover medicines. For healthcare facilities, priorities include infection prevention, accurate diagnosis and responsible prescribing.

Public health authorities must continue strengthening surveillance and ensuring that resistance data are translated into practical guidance for clinicians.

A coordinated approach involving human health, animal health and environmental management will be necessary to slow the spread of resistant microorganisms.

Protecting the effectiveness of existing antibiotics is essential to maintaining the ability to treat infections and deliver modern medical care safely. The success of these efforts will depend on sustained investment, informed prescribing and cooperation across the healthcare system.